Universe Pharmaceuticals INC Proceeds from (Repayments of) Related Party Debt
Universe Pharmaceuticals INC (UPC) reported Proceeds from (Repayments of) Related Party Debt of $3.21 billion for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2026-01-29
| Period end | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 12 month | Proceeds from (Repayments of) Related Party Debt 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $3.21B 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $9.53B 20-F · filed 2026-01-29 | $6.72M 20-F · filed 2025-04-29 | |
| 2024-03-31 | $5.10M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $3.54B 20-F · filed 2026-01-29 | -$3.09M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $2.08M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $3.32M 20-F · filed 2025-04-29 | ||
| 2022-03-31 | -$19.99K 6-K · filed 2022-08-16 | ||
| 2021-09-30 | -$911.65K 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $2.19M 6-K · filed 2022-08-16 |